Ripfit Peptides

Product Details

ARA-290 is an 11-amino-acid peptide derivative of erythropoietin (EPO) designed to selectively target the innate repair receptor (IRR) without activating erythropoiesis. In preclinical research, ARA-290 is studied for its potential to modulate inflammatory signaling, neuropathic pathways, and tissue-protection mechanisms while avoiding hematopoietic effects associated with full-length EPO. Experimental models have explored its influence on cytokine balance, cellular stress responses, and neuroimmune interactions, making it a valuable reagent for investigating non-erythropoietic EPO signaling and its downstream biological effects.

For laboratory and in-vitro research only. Not for human consumption. COAs available on request.